
Baxter International guidance
$25.54−1.05%Close 16 Nov 2026 · Market value $13.38B
In its results release of 29 Oct 2026 (Q3 FY2026), Baxter International gave 2 forecasts in figures, among them EPS (adjusted) of $2.05 to $2.15 for FY2026.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q3 FY2026 results, 29 Oct 2026
| Measure | Period | Guidance | As stated |
|---|
| Organic revenue growth | FY2026 | +3% to +4% | Organic sales growth from continuing operations: 3% to 4% (previously 2% to 3%) |
|---|
| EPS · Adjusted | FY2026 | $2.05 to $2.15 | Adjusted diluted EPS $2.05 - $2.15 |
|---|
Source: the company's earnings release.
Guidance against results above 1 · within 0 · below 1
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| Organic revenue growth | FY2026 | +3% to +4% | Raised once | — | To come |
|---|
| EPS · Adjusted | FY2026 | $2.05 to $2.15 | Raised twice | — | To come |
|---|
| EPS · Adjusted | Q4 FY2025 | $0.52 to $0.57 | Given once | $0.44 | Below the range |
|---|
| EPS · Adjusted | Q3 FY2025 | $0.58 to $0.62 | Given once | $0.69 | Above the range |
|---|
| Revenue growth | FY2024 | +1% to +2% | Given once | +2.66% | Above the range |
|---|
BAX in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.